Back

ACEIs versus ARBs in HIV Patients

2026-01-15 hiv aids Title + abstract only
View on medRxiv
Show abstract

BackgroundAngiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are established antihypertensive treatments that reduce cardiovascular disease (CVD) risk. However, their comparative effectiveness in people with HIV (PWH) is not well examined. This study evaluated the comparative effectiveness of ACEIs and ARBs head-to-head and versus no antihypertensive treatment in preventing primary CVD. MethodsUsing a target trial emulation framework and data from the Nort...

Predicted journal destinations